Back to RecallTracker
Health Canada Health products

Breast Implants - Risk of Anaplastic Large Cell Lymphoma (BIA-ALCL)

Issued November 24, 2017
Issue
A safety review on the risk of BIA-ALCL was initiated by Health Canada to determine a Canadian-specific rate of BIA-ALCL cases relative to the number of implants sold over the past 10 years. The safety review determined that the rate of BIA-ALCL reported to Health Canada is low and cases are mainly associated with breast implants with textured surfaces.
Hazard description
New safety information